Identification of Educational Gaps Among Oncologists Who Manage Patients with Pancreatic Cancer.

Introduction: Pancreatic ductal adenocarcinoma (PDA) is associated with poor outcomes and presents oncologists with a myriad of clinical challenges. This study was conducted to assess oncologists' practice patterns and to identify the greatest areas of need for future PDA continuing medical education (CME) programs.

Methods: Case vignettes have been validated as an effective tool to assess how physicians approach and treat a wide array of diseases.

Probiotic properties of Oxalobacter formigenes: an in vitro examination.

Oxalobacter formigenes (O. formigenes) is a nonpathogenic, Gram-negative, obligate anaerobic bacterium that commonly inhabits the human gut and degrades oxalate as its major energy and carbon source. Results from a case-controlled study suggested that lack of O.

Response of germ-free mice to colonization with O. formigenes and altered Schaedler flora.

Unlabelled: Colonization with Oxalobacter formigenes may reduce the risk of calcium oxalate kidney stone disease. To improve our limited understanding of host/O.formigenes and microbe/O.

Oxalobacter formigenes Colonization and Oxalate Dynamics in a Mouse Model.

Animal and human studies have provided compelling evidence that colonization of the intestine with Oxalobacter formigenes reduces urinary oxalate excretion and lowers the risk of forming calcium oxalate kidney stones. The mechanism providing protection appears to be related to the unique ability of O. formigenes to rely on oxalate as a major source of carbon and energy for growth.

Analysis of commercial kidney stone probiotic supplements.

Objective: To examine the levels of Oxalobacter formigenes in probiotic supplements marketed by PRO-LAB, Ltd, Toronto, Canada, and capsules of Oxalo purchased from Sanzyme Ltd, Hyderabad, India, and to measure the ability of these preparations to degrade oxalate in vitro.

Methods: Probiotic supplements and pure cultures of O. formigenes were cultured in a number of media containing oxalate.

The importance of dual 5alpha-reductase inhibition in the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride versus finasteride.

Background: Male pattern hair loss (MPHL) is a potentially reversible condition in which dihydrotestosterone is an important etiologic factor.

Objective: Our aim was to evaluate the efficacy of the type 1 and 2 5alpha-reductase inhibitor dutasteride in men with MPHL.

Methods: Four hundred sixteen men, 21 to 45 years old, were randomized to receive dutasteride 0.